Professor Jacob Sherkow travelled to Cologne, Germany, in September to deliver a lecture as part of the CMMC Symposium in Molecular Medicine. The Symposium was titled "From Concepts to Clinic: a New Era of Nucleic Acid Therapeutics," and aimed to provide attendees with an in-depth understanding of the chemical, biological and clinical challenges in the field. Sherkow presented a speech titled "Nucleic Acid Platforms: US and EU regulatory challenges," which was part of the preclinical and clinical application portion of the proceedings.